NCT07325214 2026-01-12
Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer
IMGT Co., Ltd.
Phase NA Not yet recruiting
Clinical Trials
12 trialsNCT05391126 2025-12-16
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
University of Kentucky
Phase NA Recruiting
NCT01847495 2024-10-04
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT05832398 2023-06-28
Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer
Nanfang Hospital, Southern Medical University
Phase NA Unknown
NCT02256800 2021-11-17
Escalated Dose of Irinotecan in mCRC
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase NA Completed
NCT01280643 2021-03-15
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Fox Chase Cancer Center
Phase NA Terminated
NCT02358863 2018-09-06
mEGA
Georgetown University
Phase NA Terminated
NCT01631539 2014-12-04
Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC
Universitaire Ziekenhuizen KU Leuven
Phase NA Withdrawn
NCT01939483 2014-10-08
A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases
University of California, Irvine
Phase NA Withdrawn
NCT01941173 2014-07-21
Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy
City of Hope Medical Center
Phase NA Withdrawn
NCT01366118 2011-06-03
TT
Grupo Hospital de Madrid
Phase NA Completed
NCT00507143 2007-07-25
Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irinotecan
National Cancer Center, Korea
Phase NA Unknown